Literature DB >> 29238809

Accreditation Readiness in US Multidisciplinary Rectal Cancer Care: A Survey of OSTRICH Member Institutions.

Lawrence Lee1, David W Dietz2, Fergal J Fleming3, Feza H Remzi4, Steven D Wexner5, David Winchester6, John R T Monson1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29238809      PMCID： PMC5933378          DOI： 10.1001/jamasurg.2017.4871

Source DB:  PubMed          Journal:  JAMA Surg        ISSN： 2168-6254            Impact factor:   14.766


× No keyword cloud information.
  6 in total

1.  The Rationale for and Reality of the New National Accreditation Program for Rectal Cancer.

Authors:  Steven D Wexner; Mariana E Berho
Journal:  Dis Colon Rectum       Date:  2017-06       Impact factor: 4.585

Review 2.  Multidisciplinary management of rectal cancer: the OSTRICH.

Authors:  David W Dietz
Journal:  J Gastrointest Surg       Date:  2013-07-25       Impact factor: 3.452

Review 3.  Workload and surgeon's specialty for outcome after colorectal cancer surgery.

Authors:  David Archampong; David Borowski; Peer Wille-Jørgensen; Lene H Iversen
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

4.  A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit.

Authors:  Arne Wibe; Bjørn Møller; Jarle Norstein; Erik Carlsen; Johan N Wiig; Richard J Heald; Frøydis Langmark; Helge E Myrvold; Odd Søreide
Journal:  Dis Colon Rectum       Date:  2002-07       Impact factor: 4.585

5.  Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography.

Authors:  John R T Monson; Christian P Probst; Steven D Wexner; Feza H Remzi; James W Fleshman; Julio Garcia-Aguilar; George J Chang; David W Dietz
Journal:  Ann Surg       Date:  2014-10       Impact factor: 12.969

6.  The impact of the Calman-Hine report on the processes and outcomes of care for Yorkshire's colorectal cancer patients.

Authors:  E Morris; R A Haward; M S Gilthorpe; C Craigs; D Forman
Journal:  Br J Cancer       Date:  2006-10-23       Impact factor: 7.640
  6 in total
  5 in total

1.  Facility Variation in Local Staging of Rectal Adenocarcinoma and its Contribution to Underutilization of Neoadjuvant Therapy.

Authors:  Douglas S Swords; Benjamin S Brooke; David E Skarda; Gregory J Stoddard; H Tae Kim; William T Sause; Courtney L Scaife
Journal:  J Gastrointest Surg       Date:  2018-11-12       Impact factor: 3.452

2.  Surgeon-Level Variation in Utilization of Local Staging and Neoadjuvant Therapy for Stage II-III Rectal Adenocarcinoma.

Authors:  Douglas S Swords; David E Skarda; William T Sause; Ute Gawlick; George M Cannon; Mark A Lewis; Courtney L Scaife; Jesse A Gygi; H Tae Kim
Journal:  J Gastrointest Surg       Date:  2019-01-31       Impact factor: 3.452

3.  A systematic review of colorectal multidisciplinary team meetings: an international comparison.

Authors:  M Fehervari; S Hamrang-Yousefi; M G Fadel; S C Mills; O J Warren; P P Tekkis; C Kontovounisios
Journal:  BJS Open       Date:  2021-05-07

4.  Prognostic factors and patients' profile in treated stage I and II lung adenocarcinoma: a Hospital's Cancer Registry-based analysis.

Authors:  Fernando Conrado Abrão; Stela Verzinhasse Peres; Igor Renato Louro Bruno de Abreu; Riad Naim Younes
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895

5.  Hospital and Surgeon Selection for Medicare Beneficiaries With Stage II/III Rectal Cancer: The Role of Rurality, Distance to Care, and Colonoscopy Provider.

Authors:  Catherine Chioreso; Xiang Gao; Irena Gribovskaja-Rupp; Chi Lin; Marcia M Ward; Mary C Schroeder; Charles F Lynch; Elizabeth A Chrischilles; Mary E Charlton
Journal:  Ann Surg       Date:  2021-10-01       Impact factor: 13.787
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.